Category: Boston

Kyruus Lands $5.5M from Highland, Venrock, Others

Boston-based Kyruus, a health-IT startup whose name I cannot spell, said today it has raised a $5.5 million Series A round led by Highland Capital Partners, Venrock, and Gerson Lehrman Group. Angel investors Jonathan Bush, Ed Park, John Goldsmith, and James Golden also participated in the financing. Kyruus has developed a software platform that includes … Continue reading “Kyruus Lands $5.5M from Highland, Venrock, Others”

XSITE 2011: The Entrepreneurship Era. The Day in Pictures

Close to 400 people showed up to Babson College last Thursday for our flagship all-day event, XSITE: The Xconomy Summit on Innovation, Technology, & Entrepreneurship. This year’s conference focused specifically on what we’ve called The Era of Entrepreneurship, taking a look at a driving force in innovation and social and economic impact. We kicked off … Continue reading “XSITE 2011: The Entrepreneurship Era. The Day in Pictures”

Tesaro Snags Huge $101M Venture Round to Develop Cancer Drugs

Who needs the risky, messy business of early drug discovery? A number of top venture capitalists and public investors have shown, through a monster $101 million Series B investment in Waltham, MA-based Tesaro, that the preferred bet of the day is on a proven team of people aspiring to push cancer drugs through the later … Continue reading “Tesaro Snags Huge $101M Venture Round to Develop Cancer Drugs”

CSN Stores, Bootstrapped No More, Takes In $165M from Battery, Spark, Great Hill, HarbourVest

So much for becoming a billion-dollar company without taking venture capital. But I guess we saw this coming. Boston-based CSN Stores, an online retailer and bootstrapped success story, has raised a first financing round of $165 million from Battery Ventures, Great Hill Partners, HarbourVest Partners, and Spark Capital. The news was reported in the Wall … Continue reading “CSN Stores, Bootstrapped No More, Takes In $165M from Battery, Spark, Great Hill, HarbourVest”

Massachusetts Startup Funding in May Stays Nearly Flat from April at $305.6M

Talk about consistent. Massachusetts startups inked $305.6 million in 36 equity-based deals in May, nearly identical to the $306 million they raised across 35 deals in April. That’s according to FundingFlash, a daily roundup of companies receiving venture capital, angel investment, and growth equity funding, provided by our data partner CB Insights. Startups in healthcare … Continue reading “Massachusetts Startup Funding in May Stays Nearly Flat from April at $305.6M”

Tesaro Garners $101,000,000 Series B Financing Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ae77edee-f1ae-427c-a5a8-1283f02e917a&Preview=1 Date 6/21/2011 Company Name Tesaro Mailing Address 135 Clarendon St. Boston, MA 02116 Company Description TESARO is a privately held oncology-focused biopharmaceutical company whose passionate associates are dedicated to improving the lives of cancer patients by developing and providing safer and more effective therapeutics and supportive care products. Website http://www.tesarobio.com Transaction … Continue reading “Tesaro Garners $101,000,000 Series B Financing Round”

Urban Interactions Obtains $1,600,000 New Financing

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=5e3ce166-f007-4e00-8f1b-1a88aca9f703&Preview=1 Date 6/21/2011 Company Name Urban Interactions Mailing Address 1056 Cambridge St. Cambridge, MA 02139 Company Description We specialize in learning about workers and matching them with the jobs that suit them best. Website http://www.urbaninteractions.com Transaction Type Venture Equity Transaction Amount $1,600,000 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were not disclosed. … Continue reading “Urban Interactions Obtains $1,600,000 New Financing”

CSN Stores Secures $165,000,000 Series A Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=6650e5f4-4f59-4bc6-8a44-c68c78037424&Preview=1 Date 6/21/2011 Company Name CSN Stores Mailing Address 177 Huntington Avenue Boston, MA 02115 Company Description Based in Boston, CSN Stores LLC began in 2002 and has grown rapidly into a Top 3 online U.S. retailer of home and office goods with 400+ employees. See our Facts at a Glance and … Continue reading “CSN Stores Secures $165,000,000 Series A Round”

Green Shoots of an Entrepreneurial Spring

[Editor’s note: Cross-posted from The Economist, 6/16/11] As the G8 last month pledged $10 billion to aid the Arab Spring to support the building of economic and political institutions, the May 24th NASDAQ debut of Russia’s $10 billion Yandex was but one of many green shoots of an equally significant Entrepreneurial Spring blossoming out from … Continue reading “Green Shoots of an Entrepreneurial Spring”

Genentech, Curis Pass Clinical Trial With Skin Cancer Drug, Look Ahead to FDA

Just when it looked like there was nothing much left to say about cancer drugs after the huge ASCO conference a couple weeks ago, here comes Genentech and Curis with another noteworthy result for skin cancer patients. South San Francisco-based Genentech, and Curis, its partner in Cambridge, MA, said that their experimental drug for a … Continue reading “Genentech, Curis Pass Clinical Trial With Skin Cancer Drug, Look Ahead to FDA”

Concert Pharmaceuticals Hits $4 Million Milestone in GSK Alliance

Lexington, MA-based Concert Pharmaceuticals announced today that it has moved three novel drug candidates forward in its pipeline—one of which earned it a $4 million milestone payment from GlaxoSmithKline (NYSE: [[ticker:GSK]]). The European drug giant allied with Concert on an HIV program in 2009, and the molecule, called CTP-298, is now the lead compound in … Continue reading “Concert Pharmaceuticals Hits $4 Million Milestone in GSK Alliance”

Pfizer’s Idea to Fix the Drug Development Crisis, Which Probably Won’t Work (But Just Might)

Big companies love acronyms, and Pfizer is no exception. So when I heard the world’s biggest drugmaker talk about using its CTI network to validate POMs, it sounded like some Dilbert-style, soul-crushing initiative going nowhere. Writing off this latest initiative would be the safe bet, as many have tried and failed to revitalize the unproductive … Continue reading “Pfizer’s Idea to Fix the Drug Development Crisis, Which Probably Won’t Work (But Just Might)”

Rants, Raves, and Rap. Pre-Lunch Soundoff at XSITE Was a Hit.

When we asked readers two weeks ago to send their biggest gripes with or suggestions for the innovation community, we told them to not hold back. Well, we got we asked for at XSITE 2011: The Entrepreneurship Era. For example: “These laws don’t need to be tweaked, they need a shotgun murder and a burial … Continue reading “Rants, Raves, and Rap. Pre-Lunch Soundoff at XSITE Was a Hit.”

OwnerIQ Lands $7,000,000 New Funding Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ece6da49-17a5-4f57-b9bd-b4be31521199&Preview=1 Date 6/20/2011 Company Name OwnerIQ Mailing Address 320 Congress Street Boston, MA 02210 Company Description OwnerIQ operates a network of consumer self-support Web sites for common household product categories. The company is pioneering the concept of Ownership Targeting, providing brand advertisers with highly customized programs to precisely target consumers based on … Continue reading “OwnerIQ Lands $7,000,000 New Funding Round”

OwnerIQ Raises $7M More

Boston-based OwnerIQ, an advertising tech startup, has closed a new $7 million financing round from existing investors including Atlas Venture, CommonAngels, Kepha Partners, and the Massachusetts Technology Development Corporation, as well as new investor Longworth Venture Partners. The news was first reported by Online Media Daily. OwnerIQ, which started in 2006, focuses on targeting advertising … Continue reading “OwnerIQ Raises $7M More”

Greenbean Recycle, WaySavvy, Strohl Medical Take Home XSITE Xpo Prizes

The first time you do something, it’s a novelty. The second time, it’s a pattern. The third time, it’s a tradition. After yesterday, the “Xpo” lightning-presentation portion of Xconomy’s annual XSITE conference now qualifies as a Boston-area tradition—one that’s so fun we think we’ll keep it around for a while. A dozen early-stage startups joined … Continue reading “Greenbean Recycle, WaySavvy, Strohl Medical Take Home XSITE Xpo Prizes”

1366 Nabs $150M DOE Loan

The U.S. Department of Energy has offered 1366 Technologies a conditional commitment for a $150 million loan guarantee, the Lexington, MA-based developer of silicon wafers for solar cells announced today.The money will go to expanding 1366’s manufacturing capabilities and building another U.S. facility for producing silicon wafers more cheaply. The company’s first facility is expected to … Continue reading “1366 Nabs $150M DOE Loan”

A Big Thank You to Our Great XSITE 2011 Speakers, Sponsors, Partners—and Attendees

The sun finally came out and heated up the day a bit yesterday—and at our XSITE 2011 conference at Babson College, things were smoking. We had a great crowd of close to 400 speakers and attendees, among them nearly 100 startups, for this year’s event, themed The Entrepreneurship Era. We had inspiring keynotes, insightful chats, … Continue reading “A Big Thank You to Our Great XSITE 2011 Speakers, Sponsors, Partners—and Attendees”

Performable Picked Up by HubSpot

Cambridge, MA-based HubSpot, a marketing tech company, has acquired fellow Cambridge startup Performable, which focuses on marketing automation. Terms of the deal weren’t announced, but Performable’s 18-person team, including founder and CEO David Cancel, will join HubSpot (now more than 260 strong) at the latter company’s headquarters on First Street. Cancel will become HubSpot’s chief … Continue reading “Performable Picked Up by HubSpot”

An Ode to Error: Entrepreneurship and the Importance of Being Wrong

Is your world view marked by a sense of hopelessness? Do you obsess about past errors? Do you tend to minimize or overlook positive news? If your answers are yes, you may not be clinically depressed. Maybe you’re just being realistic. Depressed people are often told they’re just not looking at things the right way. … Continue reading “An Ode to Error: Entrepreneurship and the Importance of Being Wrong”

Constellation Pharma Raises More Money and Further Defines Pipeline

When Xconomy last checked in on Cambridge, MA, epigenetics startup Constellation Pharmaceuticals, in the fall of 2009, CEO Mark Goldsmith declined to disclose details about the company’s pipeline. These days, he’s willing to be a little more forthcoming. On June 6, during the American Society of Clinical Oncology meeting in Chicago, Constellation announced it had … Continue reading “Constellation Pharma Raises More Money and Further Defines Pipeline”

Aylus Grabs $16M To Better Enable Mobile Video Calling

Aylus Networks has brought in $16 million in equity financing for its technology that seeks to make video communication on the mobile as seamless and innate as voice communication. The deal, being announced today, was led by London-based m8 Capital, and included previous backers Matrix Partners and North Bridge Venture Partners. “We believe that video … Continue reading “Aylus Grabs $16M To Better Enable Mobile Video Calling”

Nuance’s Seattle Office: The ‘Other Guys’ from Tegic and Their Fellow Startup Vets Build A Mobile Innovation Hub

Brad Bargen knows a thing or two about being acquired—he’s actually been through it five times, dating back to General Motors’ 1985 deal for Hughes Aircraft. In the latest phase of his career, Bargen is a leader in Nuance Communications’ mobile R&D hub in Seattle, one of the nation’s most longstanding and vibrant innovation centers … Continue reading “Nuance’s Seattle Office: The ‘Other Guys’ from Tegic and Their Fellow Startup Vets Build A Mobile Innovation Hub”

Biogen Idec CEO on Move Back to Cambridge: “We’re Working on It”

Biogen Idec, after weeks of speculation in the local real estate market, has confirmed it is considering options to move its headquarters back from the suburbs to Cambridge, MA, as CEO George Scangos seeks to foster a more close-knit culture between the company’s R&D and commercial operations. “We’re working on it. We’ll see if it’s … Continue reading “Biogen Idec CEO on Move Back to Cambridge: “We’re Working on It””

RF Biocidics Secures $10,000,000 New Funding

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f9c3da25-2d39-4df1-b253-c1daa1452bf4&Preview=1 Date 6/16/2011 Company Name RF Biocidics Mailing Address 33 Arch Street Boston, MA 02110 Company Description RF Biocidics is developing and commercializing technology that helps disinfect and disinfest pests and pathogens from agricultural food and non-food commodities, both on the surface and interior without chemical pesticides or dangerous radiation. Website http://www.alliedminds.com/Portfolio/RF_Biocidics/index.htm … Continue reading “RF Biocidics Secures $10,000,000 New Funding”

Aylus Networks Lands $16,000,000 Series D Financing

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=856b2bea-042b-4346-84c0-f65873f5e004&Preview=1 Date 6/16/2011 Company Name Aylus Networks Mailing Address 238 Littleton Road Westford, MA 01886 Company Description Aylus has developed revolutionary share services that will transform the way mobile subscribers communicate in emerging wireless networks. Website http://www.aylus.com Transaction Type Venture Equity Transaction Amount $16,000,000 Transaction Round Series D Proceeds Purposes This financing … Continue reading “Aylus Networks Lands $16,000,000 Series D Financing”

HubSpot Acquires Performable for Undisclosed Sum

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=fdb9b21e-0963-4675-b6af-8aca62ffc63a&Preview=1 Date 6/16/2011 Company Name Performable Mailing Address 486 Green St. Cambridge, MA 02139 Company Description Performable is the lifecycle marketing company, transforming how the next generation of marketing, technology and sales teams work together to build lasting customer relationships. Performable’s software is ideal for companies that need to measure activity across … Continue reading “HubSpot Acquires Performable for Undisclosed Sum”

Nuance to Acquire Speech Software Firm SVOX

[Updated 6/17/11 with terms. See below] Some big news in the world of speech software today. Burlington, MA-based Nuance Communications (NASDAQ: [[ticker:NUAN]]) is acquiring Zurich-based embedded speech software firm SVOX, Xconomy has learned from a source with knowledge of the deal. The acquisition price wasn’t disclosed, but is said to be in the triple-digit millions … Continue reading “Nuance to Acquire Speech Software Firm SVOX”

Just Write Checks, Be Humble but Unstoppable, and Boston VCs Are Dinosaurs: 10 Highlights from Angel Bootcamp

The pace of tech startup events is a little out of control this week. You can thank (or curse) David Beisel, Jon Pierce, Coolio, TechStars, DartBoston, Xconomy, and many others for that. With some more time and distance, though, we might all look back at this week as a flashpoint in history when the tech … Continue reading “Just Write Checks, Be Humble but Unstoppable, and Boston VCs Are Dinosaurs: 10 Highlights from Angel Bootcamp”

Aveo Gets $100M in Stock Offering

Cambridge, MA-based Aveo Pharmaceuticals (NASDAQ: [[ticker:AVEO]]) said today it has raised another $100 million. The company sold 5.75 million shares at $17.50 apiece in an underwritten offering managed by JP Morgan Securities, Jefferies & Co., and Canaccord Genuity. Aveo, the developer of cancer drugs, said in its most recent quarterly report that it had about … Continue reading “Aveo Gets $100M in Stock Offering”

Next 3 to Buy XSITE 2011 Tickets Get These 3 Great Prizes—Think High Speed and High Fashion

We try to avoid the obvious pun around here,* but we are excited about XSITE 2011, our big full-day conference, which takes place tomorrow at Babson College in Wellesley, MA. We have had an outstanding response to this year’s event, with more than 400 people signed up—including around 100 startups (you can see the lineup … Continue reading “Next 3 to Buy XSITE 2011 Tickets Get These 3 Great Prizes—Think High Speed and High Fashion”

iPierian Shakeup Continues, as Chairman Corey Goodman, Scientist Doug Melton Exit Stem Cell Startup

Two of the leaders at iPierian, the high-profile stem cell startup in South San Francisco co-founded by scientists at the Harvard Stem Cell Institute, have left the company in the wake of its strategic shift this spring, Xconomy has learned. Corey Goodman, the prominent neuroscientist and biotech executive, has resigned his position as chairman of … Continue reading “iPierian Shakeup Continues, as Chairman Corey Goodman, Scientist Doug Melton Exit Stem Cell Startup”

Startup Weekend, Looking to Strengthen Communities for Entrepreneurs, Builds New Startup Foundation in Seven Cities

Startup Weekend, the create-a-company cram session that has spread worldwide in just a few years, is branching out in a big way. The Seattle-based nonprofit tells Xconomy it is creating a sister organization called the Startup Foundation, aimed at establishing a permanent hub for local entrepreneurial communities around the globe. The new project has backing … Continue reading “Startup Weekend, Looking to Strengthen Communities for Entrepreneurs, Builds New Startup Foundation in Seven Cities”

Vertex Pays $60M for Alios Drugs, PKE Acquires Dexela, AisleBuyer Grabs $7.5M, & More Boston-Area Deals News

New England software and drug developers inked partnerships, financings, and acquisitions deals this week. —Admantx, a Hartford, CT-based provider of semantic-based online advertising technology, pulled in $2.8 million from Atlante Ventures Mezzogiorno, the venture capital fund of the Italian bank Intesa Sanpaolo. Admantx, which was spun off last year from the semantic software firm Expert … Continue reading “Vertex Pays $60M for Alios Drugs, PKE Acquires Dexela, AisleBuyer Grabs $7.5M, & More Boston-Area Deals News”

Despite Early “Victories,” Medical Device Industry Continues To Face Uphill Slog in Washington DC

From a $20 billion industry tax to pay for healthcare reform to the Food and Drug Administration’s plans to toughen the 510(k) approval program, the medical device industry hasn’t had much to cheer about of late. However, things were starting to look up this year. After a slow start, the industry began to mobilize its … Continue reading “Despite Early “Victories,” Medical Device Industry Continues To Face Uphill Slog in Washington DC”

Chiasma Obtains $1,000,000 New Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=7e7e75bb-4397-409b-a15d-69a69f7996ee&Preview=1 Date 6/15/2011 Company Name Chiasma Mailing Address 831 Beacon St. Newton Center, MA 02459 Company Description Chiasma develops innovative solutions for the non-invasive delivery of protein drugs. Chiasma’s technology enables drugs to be administered into the bloodstream without the need for injections. Website http://www.chiasmapharma.com Transaction Type Debt Transaction Amount $1,000,000 Transaction … Continue reading “Chiasma Obtains $1,000,000 New Round”

Emerging Travel Secures $15,794,806 Series A Financing Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=5c5ffe8c-994d-482f-8f6b-318ae11c4c09&Preview=1 Date 6/15/2011 Company Name Emerging Travel Mailing Address 20 University Rd. Fourth Floor Cambridge, MA 02138 Company Description The company is developing a travel oriented website.. Website Undisclosed Transaction Type Venture Equity Transaction Amount $15,794,806 Transaction Round Series A Proceeds Purposes Proceeds purposes were not disclosed. SEC regulatory filing. M&A Terms … Continue reading “Emerging Travel Secures $15,794,806 Series A Financing Round”

TrioMed Innovations Secures $6,000,000 New Financing

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=4ec82d55-3531-42e4-912d-8bee0f172541&Preview=1 Date 6/15/2011 Company Name TrioMed Innovations Mailing Address 1191 South Brownell Road Williston, VT 05495 Company Description The company is focused on antimicrobial products such as respirators and masks. Website Undisclosed Transaction Type Venture Equity Transaction Amount $6,000,000 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were not disclosed. SEC regulatory filing. … Continue reading “TrioMed Innovations Secures $6,000,000 New Financing”

PKE Acquires Dexela

PerkinElmer (NYSE: [[ticker:PKI]]), a Waltham, MA-based maker of tools for the life sciences industry, announced today that it has bought London-based Dexela, a developer of X-ray detection technology. Financial terms of the deal weren’t revealed. The acquisition adds to Perkin’s portfolio of medical imaging technology for surgery, dental CT, cardiology, and mammography applications, the company … Continue reading “PKE Acquires Dexela”

Startup Attendees and Speakers Flock To XSITE for Full-Day Summit on The Entrepreneurship Era

[Updated 6/15/11, 5:55 pm]. See below Earlier this year, it seems that Washington, DC (and much of the rest of the country) started to identify something that we here at Xconomy have known since our inception: that entrepreneurship will be a major force in driving technology breakthroughs and economic growth. So what better time to … Continue reading “Startup Attendees and Speakers Flock To XSITE for Full-Day Summit on The Entrepreneurship Era”

60 Seconds with Smarterer CEO Jennifer Fremont-Smith

Smarterer, a Boston-based tech startup, is generating some buzz this week, having demoed its product at the WebInno meeting last night. The company started in the fall of 2010, founded by Dave Balter, Jennifer Fremont-Smith, and Michael Kowalchik. It provides crowdsourced skills tests on digital, social, and other techie tools—think Twitter, Ruby, Matlab, Photoshop. Job … Continue reading “60 Seconds with Smarterer CEO Jennifer Fremont-Smith”

Innovation at Large Scale: A Glimpse of this Thursday’s XSITE Keynote by Intellectual Ventures’ Edward Jung

Every day in the world’s great science and technology clusters, brilliant people go to work thinking about innovation—how to innovate in research, how to build and grow startups, how to keep innovating at public companies so the startups don’t eat their lunch. Edward Jung admires all that work, but believes it can only go so … Continue reading “Innovation at Large Scale: A Glimpse of this Thursday’s XSITE Keynote by Intellectual Ventures’ Edward Jung”

Hero’s Journey: A Look Inside This Year’s Class of TechStars Boston Startups

Incubator, schmincubator. The innovation community has had its fill of incubators and accelerators, hasn’t it? Well, this one is a little different. As echoes of Commencement speeches die down around town, it’s fitting that the 12-week startup bootcamp known as TechStars Boston is graduating its newest class of companies tomorrow. What’s interesting about this group—compared … Continue reading “Hero’s Journey: A Look Inside This Year’s Class of TechStars Boston Startups”

General Dynamics Acquires Fortress Technologies for Undisclosed Sum

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=113b4d96-88ed-49f5-a587-dfc53b48a50b&Preview=1 Date 6/14/2011 Company Name Fortress Technologies Mailing Address 1 Technology Park Drive Westford, MA 01886 Company Description Fortress Technologies offers a flexible security platform to address the risks and vulnerabilities of wireless networking. The Fortress Security System delivers privacy, access control and policy management through a highly scalable, centrally managed system. … Continue reading “General Dynamics Acquires Fortress Technologies for Undisclosed Sum”

Termeer Joins Verastem Board

Henri Termeer, the former CEO of Cambridge, MA-based Genzyme, has joined the board of Verastem, a startup seeking to develop treatments against cancer stem cells. Verastem, co-founded by MIT biologists Robert Weinberg and Eric Lander, raised $16 million last November, in a round that included Longwood Founders Fund, Bessemer Venture Partners, Cardinal Partners, and MPM … Continue reading “Termeer Joins Verastem Board”

Synageva to Merge With Trimeris

Lexington, MA-based Synageva BioPharma, a developer of drugs for rare diseases, announced today that it will be merging with Durham, NC-based viral disease drug developer Trimeris (NASDAQ: [[ticker:TRMS]]) in an all-stock deal.  The combined company will be called Synageva BioPharma and will be led by the Synageva management team. The new publicly traded company will … Continue reading “Synageva to Merge With Trimeris”

PureTech Ventures Launches Tal Medical To Develop Magnetic-Field Treatment for Depression

Today a company called Tal Medical is starting up in Boston with the goal of developing an entirely new approach to treating depression, inspired by a specific type of magnetic field found in some MRI imaging machines. The research is still very early, but the treatment—developed at McLean Hospital in Belmont, MA—was promising enough to … Continue reading “PureTech Ventures Launches Tal Medical To Develop Magnetic-Field Treatment for Depression”

Vertex Adds New HepC Drugs for $60M

Cambridge, MA-based Vertex Pharmaceuticals (NASDAQ: [[ticker:VRTX]]) said today it has agreed to pay $60 million upfront, as much as $715 million in development milestone payments over time, and potentially $750 million in sales milestones, to obtain a worldwide license to a couple new hepatitis C drug candidates from South San Francisco-based Alios Biopharma. The two … Continue reading “Vertex Adds New HepC Drugs for $60M”